These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 15176943)

  • 1. Vaccination as a treatment for breast or ovarian cancer.
    Holmberg LA; Sandmaier B
    Expert Rev Vaccines; 2004 Jun; 3(3):269-77. PubMed ID: 15176943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer vaccines: current research and future prospects.
    Cameron DA
    Expert Rev Vaccines; 2002 Jun; 1(1):29-34. PubMed ID: 12908510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccine immunotherapy in breast cancer treatment: promising, but still early.
    Curigliano G; Spitaleri G; Dettori M; Locatelli M; Scarano E; Goldhirsch A
    Expert Rev Anticancer Ther; 2007 Sep; 7(9):1225-41. PubMed ID: 17892423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Harnessing the immune system for ovarian cancer therapy.
    Odunsi K; Sabbatini P
    Am J Reprod Immunol; 2008 Jan; 59(1):62-74. PubMed ID: 18154597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccination with Theratope (STn-KLH) as treatment for breast cancer.
    Holmberg LA; Sandmaier BM
    Expert Rev Vaccines; 2004 Dec; 3(6):655-63. PubMed ID: 15606349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The immune response to breast cancer, and the case for DC immunotherapy.
    Allan CP; Turtle CJ; Mainwaring PN; Pyke C; Hart DN
    Cytotherapy; 2004; 6(2):154-63. PubMed ID: 15203992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Biologic therapy and epithelial ovarian cancer].
    Porpiglia M; Vicelli R; Durando A; Fracchioli S; Puopolo M; Katsaros D; Bellino R; Benedetto C
    Minerva Ginecol; 2004 Feb; 56(1):91-104. PubMed ID: 14973413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer vaccines: promise for the future or pipe dream?
    Mittendorf EA; Peoples GE; Singletary SE
    Cancer; 2007 Oct; 110(8):1677-86. PubMed ID: 17763371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccine-based clinical trials in ovarian cancer.
    Leffers N; Daemen T; Boezen HM; Melief KJ; Nijman HW
    Expert Rev Vaccines; 2011 Jun; 10(6):775-84. PubMed ID: 21692699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer vaccines: maximizing cancer treatment by tapping into host immunity.
    Emens LA; Reilly RT; Jaffee EM
    Endocr Relat Cancer; 2005 Mar; 12(1):1-17. PubMed ID: 15788636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A paradigm shift in therapeutic vaccination of cancer patients: the need to apply therapeutic vaccination strategies in the preventive setting.
    Gray A; Raff AB; Chiriva-Internati M; Chen SY; Kast WM
    Immunol Rev; 2008 Apr; 222():316-27. PubMed ID: 18364011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current approaches in ovarian cancer vaccines.
    Reinartz S; Wagner U
    Minerva Ginecol; 2004 Dec; 56(6):515-27. PubMed ID: 15729204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunologic approaches to ovarian cancer treatment.
    Sabbatini P; Odunsi K
    J Clin Oncol; 2007 Jul; 25(20):2884-93. PubMed ID: 17617519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunology and breast cancer: therapeutic cancer vaccines.
    Curigliano G; Rescigno M; Goldhirsch A
    Breast; 2007 Dec; 16 Suppl 2():S20-6. PubMed ID: 17706425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune therapy for ovarian cancer: promise and pitfalls.
    Thibodeaux SR; Curiel TJ
    Int Rev Immunol; 2011; 30(2-3):102-19. PubMed ID: 21557637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies and vaccines--hope or illusion?
    Jäger D; Knuth A
    Breast; 2005 Dec; 14(6):631-5. PubMed ID: 16242931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer vaccines: challenges and outlook in the field.
    Paul S; Acres B; Limacher JM; Bonnefoy JY
    IDrugs; 2007 May; 10(5):324-8. PubMed ID: 17487784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the HER2/neu-derived peptide GP2 for use in a peptide-based breast cancer vaccine trial.
    Mittendorf EA; Storrer CE; Foley RJ; Harris K; Jama Y; Shriver CD; Ponniah S; Peoples GE
    Cancer; 2006 Jun; 106(11):2309-17. PubMed ID: 16596621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel adjuvant Ling Zhi-8 for cancer DNA vaccines.
    Chu CL; Chen DzC; Lin CC
    Hum Vaccin; 2011 Nov; 7(11):1161-4. PubMed ID: 22048115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccines: an innovative approach to treating cancer.
    Pazdur MP; Jones JL
    J Infus Nurs; 2007; 30(3):173-8. PubMed ID: 17505219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.